BIOMARIN PHARMACEUTICAL INC Purchase Commitment, Remaining Minimum Amount Committed
BIOMARIN PHARMACEUTICAL INC (BMRN) had Purchase Commitment, Remaining Minimum Amount Committed of $171.50 million as of 2022-09-30, per its 10-Q filed 2022-10-28.
Discontinued › Notes › Commitment and Contingencies
us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted · last filed 2022-10-28
- 2022-09-30: Purchase Commitment, Remaining Minimum Amount Committed $171.50M.
- 2022-06-30: Purchase Commitment, Remaining Minimum Amount Committed $140.80M.
- 2022-03-31: Purchase Commitment, Remaining Minimum Amount Committed $117.50M.
- 2021-09-30: Purchase Commitment, Remaining Minimum Amount Committed $107.70M.
| Period end | Purchase Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2022-09-30 | $171.50M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $140.80M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $117.50M 10-Q · filed 2022-04-29 |
| 2021-09-30 | $107.70M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $126.70M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $122.90M 10-Q · filed 2021-04-30 |
| 2014-12-31 | $61.00M 10-K · filed 2015-03-02 |
| 2013-12-31 | $38.20M 10-K · filed 2014-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |